Market Research Logo

Europe Blood Screening Market Size, Share & Trends Analysis Report By Technology (NAT, ELISA, CLIA, NGS, Western Blotting), By Product (Reagents, Instruments), And Segment Forecasts, 2018 - 2025

Europe Blood Screening Market Size, Share & Trends Analysis Report By Technology (NAT, ELISA, CLIA, NGS, Western Blotting), By Product (Reagents, Instruments), And Segment Forecasts, 2018 - 2025

The Europe blood screening market size is expected to reach USD 1.17 billion by 2025 according to a new report by Grand View Research, Inc. The market is expected to record a CAGR of 7.7% during the forecast period. Increasing number of blood transfusion processes performed along with stringent regulations in Europe mandating screening tests, such as NAT for testing HIV, HBV, and HCV, is contributing to the market growth.

Moreover, growth in the overall number of complex surgeries that require a large amount of blood and blood products along with rising cases of road accidents is expected to drive the market further. Additionally, import of products through contract agreements and development in the product technology by manufacturers of blood screening reagents and instruments are contributing to market expansion in the region.

For example, DiaSystem Scandinavia AB signed a distribution agreement with SNIBE, an Asian immunology test producer that focuses on immunoassay analyzers based on CLIA technology. DiaSystem specializes in the production and supply of reagents used in chemistry and immunoturbidimetry. This agreement has provided the former company with automated chemiluminescence instrument delivering a complete analytical system in areas, such as thyroid, renal function, hepatitis, and hepatic fibrosis.

Further key findings from the study suggest:

  • NAT led the technology segment in 2017 owing to a regulatory obligation for mandatory NAT screening for all blood donations.
  • On the basis of product, reagents led the Europe blood screening market in 2017
  • Germany held a majority of the market share in 2017 due to large number of blood donors.
  • Moreover, stringent regulations in the country for screening of donations also contributed to its growth. The Paul-Ehrlich-Institut, a medical regulatory body in Germany, mandates NAT testing for HCV and HIV for all blood donations.
  • Roche Diagnostics; Bio-Rad Laboratories, Inc.; Siemens Healthcare GmbH; Grifols, S.A.; Becton, Dickinson and Company; Agilent Technologies; Thermo Fisher Scientific, Inc.; and Danaher Corp. are some of the key companies operating in this market.
Please note The report will be updated with the latest data and delivered to you within 3-4 business days.


Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Scope and Assumptions
1.3 List to Data Sources
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Europe Blood Screening Market Variables, Trends & Scope
3.1 Market Segmentation
3.2 Europe Blood Screening Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Growing demand for blood for transfusion
3.2.1.2 Stringent Government regulations
3.2.2 Market RESTRAINTS Analysis
3.2.2.1 Insufficient blood donations
3.2.2.2 High operating cost of NAT
3.2.3 Penetration & Growth Prospects Mapping
3.2.4 Europe Blood Screening Market - PESTLE Analysis
3.2.5 Industry Analysis - Porter’s
3.3 List of Diagnostic Centres in Europe
3.4 Pricing Analysis
Chapter 4 Europe Blood Screening Market: Technology Estimates & Trend Analysis
4.1 Europe Blood Screening Market: Technology Movement Analysis
4.2 Nucleic Acid Amplification Test (NAT)
4.2.1 Europe NAT market Estimates and Forecasts, 2014 - 2025 (USD Million)
4.3 Enzyme-Linked Immunosorbent Assay (ELISA)
4.3.1 Europe ELISA market estimates and forecasts, 2014 - 2025 (USD Million))
4.4 Chemiluminescence Immunoassay (CLIA)
4.4.1 Europe CLIA market estimates and forecasts, 2014 - 2025 (USD Million)
4.5 Next-Generation Sequencing (NGS)
4.5.1 Europe NGS market estimates and forecasts, 2014 - 2025 (USD Million)
4.6 Western Blotting
4.6.1 Europe western blotting market estimates and forecasts, 2014 - 2025 (USD Million)
Chapter 5 Europe Blood Screening Market: Product Estimates & Trend Analysis
5.1 Europe Blood Screening Market: Product Movement Analysis
5.2 Reagents
5.2.1 Europe reagents market estimates and forecasts, 2014 - 2025 (USD Million)
5.3 Instruments
5.3.1 Europe instruments market estimates and forecasts, 2014 - 2025 (USD Million)
Chapter 6 Europe Blood Screening Market: Regional Estimates & Trend Analysis, by Technology & Products
6.1 Europe Blood Screening Market: Regional Movement Analysis, 2017 & 2025, USD Million
6.2 Europe
6.2.1 Europe blood screening market estimates and forecasts, 2014 - 2025 (USD Million)
6.2.2 U.K.
6.2.2.1 U.K. blood screening market estimates and forecasts, 2014 - 2025 (USD Million)
6.2.3 Germany
6.2.3.1 Germany blood screening market estimates and forecasts, 2014 - 2025 (USD Million)
6.2.4 France
6.2.4.1 France blood screening market estimates and forecasts, 2014 - 2025 (USD Million)
6.2.5 Italy
6.2.5.1 Italy blood screening market estimates and forecasts, 2014 - 2025 (USD Million)
6.2.6 SPAIN
6.2.6.1 Spain blood screening market estimates and forecasts, 2014 - 2025 (USD Million)
Chapter 7 Competitive Landscape
7.1 Strategic Framework
7.2 Europe Blood Screening Market: Market Position Analysis (Based on Application, Product Benchmarking, Regional Presence, and Recent Updates)
7.3 Company Profiles
7.3.1 Roche Diagnostics
7.3.1.1 Company Overview
7.3.1.2 Financial performance
7.3.1.3 Product benchmarking
7.3.1.4 Strategic initiatives
7.3.2 Bio-Rad Laboratories, Inc.
7.3.2.1 Company Overview
7.3.2.2 Financial performance
7.3.2.3 Product benchmarking
7.3.2.4 Strategic initiatives
7.3.3 Siemens Healthcare GmBH
7.3.3.1 Company Overview
7.3.3.2 Financial performance
7.3.3.3 Product benchmarking
7.3.3.4 Strategic initiatives
7.3.4 Grifols, S.A.
7.3.4.1 Company Overview
7.3.4.2 Financial performance
7.3.4.3 Product benchmarking
7.3.4.4 Strategic initiatives
7.3.5 Becton, Dickinson and Company
7.3.5.1 Company Overview
7.3.5.2 Financial performance
7.3.5.3 Product benchmarking
7.3.5.4 Strategic initiatives
7.3.6 Agilent Technologies
7.3.6.1 Company Overview
7.3.6.2 Financial performance
7.3.6.3 Product benchmarking
7.3.7 Thermo Fisher Scientific, Inc.
7.3.7.1 Company Overview
7.3.7.2 Financial performance
7.3.7.3 Product benchmarking
7.3.7.4 Strategic initiatives
7.3.8 Danaher
7.3.8.1 Company Overview
7.3.8.2 Financial performance
7.3.8.3 Product benchmarking
7.3.8.4 Strategic initiatives
List of Tables
Table 1 Europe Blood Screening Market: Pricing Analysis, 2017
Table 2 Europe blood screening market, by country, 2014 - 2025 (USD Million)
Table 3 Europe blood screening market, by technology, 2014 - 2025 (USD Million)
Table 4 Europe blood screening market, by product, 2014 - 2025 (USD Million)
Table 5 U.K. blood screening market, by technology, 2014 - 2025 (USD Million)
Table 6 U.K. blood screening market, by product, 2014 - 2025 (USD Million)
Table 7 Germany blood screening market, by technology, 2014 - 2025 (USD Million)
Table 8 Germany blood screening market, by product, 2014 - 2025 (USD Million)
Table 9 France blood screening market, by technology, 2014 - 2025 (USD Million)
Table 10 France blood screening market, by product, 2014 - 2025 (USD Million)
Table 11 Italy blood screening market, by technology, 2014 - 2025 (USD Million)
Table 12 Italy blood screening market, by product, 2014 - 2025 (USD Million)
Table 13 Spain blood screening market, by technology, 2014 - 2025 (USD Million)
Table 14 Spain blood screening market, by product, 2014 - 2025 (USD Million)
List of Figures
Fig.1 Europe Blood Screening market: Market snapshot, USD Million, 2017
Fig.2 Europe blood screening market segmentation
Fig.3 Europe Blood Screening market dynamics
Fig.4 Europe Blood Screening market driver impact
Fig.5 Fig.4 Europe Blood Screening market restraints impact
Fig.6 Penetration & Growth Prospects Mapping
Fig.7 Europe Blood Screening market - PESTLE Analysis
Fig.8 Industry Analysis - Porter’s
Fig.9 Europe Blood Screening market, Technology outlook: key takeaways, USD Million
Fig.10 Europe Blood Screening market: Technology movement analysis (USD Million)
Fig.11 Europe NAT market estimates and forecasts, 2014 - 2025 (USD Million)
Fig.12 Europe ELISA market estimates and forecasts, 2014 - 2025 (USD Million)
Fig.13 Europe CLIA market estimates and forecasts, 2014 - 2025 (USD Million)
Fig.14 Europe NGS market estimates and forecasts, 2014 - 2025 (USD Million)
Fig.15 Europe western blotting market estimates and forecasts, 2014 - 2025 (USD Million)
Fig.16 Europe Blood Screening Market, Product outlook key takeaways (USD Million)
Fig.17 Europe Blood Screening Market: Product movement analysis (USD Million)
Fig.18 Europe reagents market estimates and forecasts, 2014 - 2025 (USD Million)
Fig.19 Europe instruments market estimates and forecasts, 2014 - 2025 (USD Million)
Fig.20 Regional market place: Key takeaways
Fig.21 Europe blood screening market: Country movement analysis (USD Million)
Fig.22 Europe blood screening market estimates and forecasts, 2014 - 2025 (USD Million)
Fig.23 U.K. blood screening market estimates and forecasts, 2014 - 2025 (USD Million)
Fig.24 Germany blood screening market estimates and forecasts, 2014 - 2025 (USD Million)
Fig.25 France blood screening market estimates and forecasts, 2014 - 2025 (USD Million)
Fig.26 Italy blood screening market estimates and forecasts, 2014 - 2025 (USD Million)
Fig.27 Spain blood screening market estimates and forecasts, 2014 - 2025 (USD Million)
Fig.28 Strategic framework
Fig.29 Europe Blood Screening Market: Market Position Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report